Cite
HARVARD Citation
Pierini, S. et al. (2021). Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression. Journal for immunotherapy of cancer. 9 (2), p. . [Online].